RxDoctor Payments Data

Sachin Sheth, MD

Vascular & Interventional Radiology · Stockbridge, GANPI 1730341710

Payments from drug & device makers

What this record shows

This record is dominated by other: $46,161 of the $46,475 with a category attached, or 99.3%. Angiodynamics, Inc. accounts for 99.3% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $24,490 and has fallen 63.5% since, to $8,930 in 2025. Among vascular & interventional radiology clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$46,475in general payments, 2019–2025

Across 18 payments — averaging $2581.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Angiodynamics, Inc.$46K
  • Medtronic$131
  • Tactile Systems Technology Inc$84
  • Boston Scientific$58
  • Cook Medical LLC$22
  • Dynavax Technologies Corporation$20

What the payments were for

  • Food & beverage$3151%
  • Other$46,16199%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$46,475 in reported general payments places this provider in the 90th percentile of 120 vascular & interventional radiology providers in Georgia.

See all vascular & interventional radiology providers in Georgia

Medicare billing

Part B allowed, 2024
$440,400
Medicare patients
124
Services billed
966

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban11$6,217

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Stockbridge

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →